Yuyu Pharma, Inc.
KRX:000220.KS
4620 (KRW) • At close January 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 137,209.589 | 138,881.056 | 115,655.485 | 98,119.846 | 90,877.644 | 83,096.445 | 62,852.074 | 71,578.932 | 69,743.375 | 62,816.223 | 61,994.115 | 61,984.734 | 58,798.714 | 52,027.334 | 47,900.307 | 45,014.225 | 73,840.117 | 73,393.135 |
| Cost of Revenue
| 88,682.353 | 85,567.913 | 70,320.1 | 52,850.892 | 44,267.329 | 42,459.508 | 32,866.391 | 38,208.092 | 38,870.768 | 31,717.19 | 29,623.079 | 26,630.246 | 25,563.803 | 21,237.479 | 21,042.15 | 18,076.88 | 26,306.445 | 26,153.156 |
| Gross Profit
| 48,527.235 | 53,313.144 | 45,335.385 | 45,268.955 | 46,610.315 | 40,636.937 | 29,985.683 | 33,370.84 | 30,872.606 | 31,099.032 | 32,371.036 | 35,354.488 | 33,234.912 | 30,789.855 | 26,858.157 | 26,937.345 | 47,533.672 | 47,239.979 |
| Gross Profit Ratio
| 0.354 | 0.384 | 0.392 | 0.461 | 0.513 | 0.489 | 0.477 | 0.466 | 0.443 | 0.495 | 0.522 | 0.57 | 0.565 | 0.592 | 0.561 | 0.598 | 0.644 | 0.644 |
| Reseach & Development Expenses
| 7,187.636 | 8,620.374 | 4,008.281 | 4,122.659 | 876.672 | 1,424.411 | 1,690.911 | 2,246.055 | 1,245.266 | 1,131.686 | 999.218 | 845.127 | 922.65 | 487.547 | 1,421.183 | 1,023.061 | 2,846.72 | 3,131.281 |
| General & Administrative Expenses
| 4,191.676 | 4,956.909 | 3,904.331 | 3,639.649 | 4,469.349 | 4,339.237 | 3,290.155 | 4,412.912 | 6,384.275 | 7,001.009 | 6,463.649 | 4,839.731 | 5,103.122 | 4,474.57 | 4,126.369 | 4,566.498 | 5,266.898 | 5,064.961 |
| Selling & Marketing Expenses
| 11,707.305 | 15,036.605 | 12,471.853 | 10,492.798 | 11,587.585 | 10,750.399 | 7,161.295 | 8,042.1 | 6,670.571 | 7,221.912 | 8,278.199 | 11,647.741 | 11,921.844 | 10,520.841 | 9,527.738 | 12,496.033 | 12,403.499 | 10,092.952 |
| SG&A
| 15,898.981 | 19,993.514 | 16,376.184 | 14,132.447 | 16,056.934 | 15,089.636 | 10,451.45 | 12,455.012 | 13,054.846 | 14,222.921 | 14,741.848 | 16,487.472 | 17,024.966 | 14,995.411 | 13,654.107 | 17,062.531 | 17,670.397 | 15,157.913 |
| Other Expenses
| 0 | 25,291.369 | 23,750.752 | 20,742.921 | 21,601.982 | 322.191 | -183.72 | 255.419 | 1,061.196 | -6,648.931 | 645.905 | 64.872 | 40.28 | 1,011.686 | 562.147 | 1,928.251 | -7.169 | 312.793 |
| Operating Expenses
| 47,254.05 | 53,905.257 | 44,135.217 | 38,998.027 | 38,535.588 | 35,309.223 | 26,417.493 | 29,635.914 | 29,258.843 | 29,728.101 | 30,615.867 | 31,635.196 | 31,133.481 | 29,496.27 | 26,270.442 | 32,671.15 | 37,529.577 | 34,169.582 |
| Operating Income
| 364.537 | 691.747 | 2,653.508 | 6,270.927 | 8,074.727 | 5,327.413 | 3,568.191 | 3,734.924 | 1,613.761 | 1,370.931 | 1,755.169 | 3,719.293 | 1,819.332 | 1,293.584 | 587.715 | -5,733.806 | 10,004.097 | 13,070.397 |
| Operating Income Ratio
| 0.003 | 0.005 | 0.023 | 0.064 | 0.089 | 0.064 | 0.057 | 0.052 | 0.023 | 0.022 | 0.028 | 0.06 | 0.031 | 0.025 | 0.012 | -0.127 | 0.135 | 0.178 |
| Total Other Income Expenses Net
| -5,806.682 | -3,218.261 | -3,036.663 | -2,559.592 | -1,474.459 | -679.483 | -1,137.353 | 2,801.934 | -2,465.996 | -9,043.509 | 223.246 | -132.029 | -212.651 | -433.544 | 2,050.245 | 279.167 | 5,571.389 | -910.405 |
| Income Before Tax
| -5,442.145 | -3,810.377 | -383.155 | 3,711.335 | 6,600.268 | 4,648.232 | 4,813.278 | 6,536.859 | -281.501 | -7,672.578 | 2,629.639 | 3,586.219 | 1,348.13 | 860.04 | 2,637.96 | -5,454.639 | 15,575.486 | 12,159.992 |
| Income Before Tax Ratio
| -0.04 | -0.027 | -0.003 | 0.038 | 0.073 | 0.056 | 0.077 | 0.091 | -0.004 | -0.122 | 0.042 | 0.058 | 0.023 | 0.017 | 0.055 | -0.121 | 0.211 | 0.166 |
| Income Tax Expense
| 98.436 | 615.016 | 537.134 | 1,298.73 | 1,036.925 | 336.122 | 524.751 | 391.285 | 122.195 | -309.227 | 697.759 | 600.247 | -560.057 | -257.232 | 364.568 | 232.737 | 2,009.372 | 3,601.561 |
| Net Income
| -7,180.9 | -4,425.393 | -920.289 | 2,412.605 | 4,722.297 | 4,020.291 | 4,541.421 | 5,885.697 | -252.675 | -7,467.373 | 1,876.522 | 2,978.727 | 1,906.769 | 1,117.272 | 2,273.392 | -5,687.375 | 13,566.114 | 8,558.432 |
| Net Income Ratio
| -0.052 | -0.032 | -0.008 | 0.025 | 0.052 | 0.048 | 0.072 | 0.082 | -0.004 | -0.119 | 0.03 | 0.048 | 0.032 | 0.021 | 0.047 | -0.126 | 0.184 | 0.117 |
| EPS
| -441.41 | -266.9 | -57.67 | 194.34 | 377.83 | 281.5 | 406 | 493.5 | -25.45 | -746.43 | 178 | 301 | 161 | 106.5 | 218 | -452.98 | 1,041 | 652.5 |
| EPS Diluted
| -441.41 | -266.9 | -57.67 | 194.34 | 376.31 | 281.5 | 400 | 493.5 | -25.45 | -746.43 | 176.5 | 301 | 161 | 106.5 | 218 | -452.98 | 1,041 | 652.5 |
| EBITDA
| 4,858.392 | 3,402.673 | 5,703.121 | 10,170.344 | 11,186.937 | 7,454.727 | 8,851.298 | 8,565.678 | 3,155.932 | -6,097.24 | 3,468.894 | 5,267.217 | 3,474.486 | 3,666.966 | 3,177.955 | -37.666 | 14,728.261 | 18,805.86 |
| EBITDA Ratio
| 0.035 | 0.041 | 0.062 | 0.095 | 0.121 | 0.099 | 0.094 | 0.083 | 0.069 | -0.08 | 0.069 | 0.092 | 0.065 | 0.09 | 0.066 | 0.008 | 0.199 | 0.251 |